Circulating tumor cells (CTC): Assessment of treatment efficacy in metastatic breast cancer (MBC)

10535 Background: Preliminary data in MBC suggest that ≥5 CTC/7.5 mL blood is associated with worse progression free survival (PFS) and overall survival (OS), and that the persistence of ≥5 CTC/7.5...